Moxifloxacin and Glucose Homeostasis.
- Published in:
- Drug Safety, 2004, v. 27, n. 9, p. 671, doi. 10.2165/00002018-200427090-00005
- By:
- Publication type:
- Article
Works matching IS 01145916 AND DT 2004 AND VI 27 AND IP 9
Results: 8
1
2
Semi-intensive versus intensive monitoring of adverse drug reactions in a hospital.
- Published in:
- 2004
- By:
- Publication type:
- Letter
3
Safety of calcium dobesilate in chronic venous disease, diabetic retinopathy and haemorrhoids.
- Published in:
- 2004
- By:
- Publication type:
- journal article
4
Dapsone Therapy for Malaria During Pregnancy.
- Published in:
- Drug Safety, 2004, v. 27, n. 9, p. 633, doi. 10.2165/00002018-200427090-00002
- By:
- Publication type:
- Article
5
Incidence and Nature of Dosing Errors in Paediatric Medications.
- Published in:
- Drug Safety, 2004, v. 27, n. 9, p. 661, doi. 10.2165/00002018-200427090-00004
- By:
- Publication type:
- Article
6
Moxifloxacin and glucose homeostasis: a pooled-analysis of the evidence from clinical and postmarketing studies.
- Published in:
- 2004
- By:
- Publication type:
- journal article
7
Dapsone therapy for malaria during pregnancy: maternal and fetal outcomes.
- Published in:
- 2004
- By:
- Publication type:
- journal article
8
Safety Profile of Tegaserod, a 5-HT<sub>4</sub> Receptor Agonist, for the Treatment of Irritable Bowel Syndrome.
- Published in:
- Drug Safety, 2004, v. 27, n. 9, p. 619, doi. 10.2165/00002018-200427090-00001
- By:
- Publication type:
- Article